We continue to see great advances in the diagnosis and treatment of gastrointestinal and liver disease. Therapy continues to evolve in multiple directions. Topics including inflammatory bowel disease, hepatitis C, among others, see approvals of multiple important new medications every year. The line between the traditional realms of endoscopy and surgery also continues to blur and it is critical for both gastroenterologists and surgeons to explore these boundaries – this includes topics like the endoscopic approaches to treating Barrett's esophagus, and biliary disease, which in the past were relegated to a surgical approach, all of which will be covered in this course.

To maintain their practices, gastroenterologists, surgeons and advanced practitioners need to stay up to date on a wide range of topics, including diagnosis of autoimmune hepatitis, understanding medical and surgical treatment strategies to chronic pancreatitis, managing colorectal cancer metastatic to the liver, and evaluating the side effect profiles of different biologic agents used in the management of inflammatory bowel disease . It is difficult for practicing physicians and surgeons to stay abreast of these new advances. The 37th Annual Medical and Surgical Gastroenterology Conference will provide a learning opportunity for participants in various GI disorders including the approach to the patient with suspected hereditary colon cancer, the calculus behind operating for arcuate ligament syndrome, and advances in robotic surgery for gastrointestinal disease.  This year we are also returning back to basics, blending in an overview of management of hernias, acute cholecystitis and appendicitis, IBD for the non-IBDologist, and fatty liver disease.  We will also continue to have a full day of interactive case presentations and attendees have the opportunity to earn maintenance of certification (MOC) points.

1. Identify and scrutinize the best approach to the management of pancreatic cancer.
2. Identify how best to treat patients with acute appendicitis and acute cholecystitis.
3. Outline the long term risks of proton pump inhibitors (PPI).
4. Describe updates to the surgical management of GI Stromal Tumors (GIST).
5. Analyze the standard of care for patients with suspected small intestinal bacterial growth (SIBO).
6. Assess the treatment approach to the patient with Irritable Bowel Disorder (IBD).

Grant Hyatt Vail

1300 Westhaven Drive

Vail, CO 81657

877-803-7534 

grandhyattvail.com

We strongly encourage you to book your accommodations at the Grand Hyatt Vail, which is the conference headquarters hotel.  The Johns Hopkins Office of CME makes every effort to secure the best rate for overnight accommodations. The rate is part of a negotiated conference package that incorporates many services. By staying at the host hotel and booking within the room block, you help us maintain current conference benefits and keep future registration fees reasonable.  Please consider this when making your overnight accommodations decision.

Hotel reservation cut-off date: December 20, 2019

 A limited block of sleeping rooms has been reserved for your convenience and will be available on a first come, first served basis.
Make your reservation online at Hyatt Reservations or call the hotel directly and specify that you are attending the Johns Hopkins 37th Medical and Surgical GI Course to receive the special group rate of $399 single or double, plus a $25 per day resort fee and tax. (Additional discount room types are available). Valet Parking is available on site for $30 per night for registered hotel guests. 

Check-in time is 4:00 p.m. Check out time is 12:00 noon.

No faculty are available for this activity at this time.